Fund VI
Size: EUR 1,900 million
Year: 2006
Investment focus/criteria:
Geographic scope:Primarily Nordic Region, selected investments in Europe
Industries:Diversified, special focus on and expertise in healthcare investments
Main focus:Large and medium-sized companies
Key Characteristics:Opportunities for structural transformation, operational improvements, buy & build, emerging market growth, strategic repositioning, international expansion and growth acceleration.
Investors:
Investors in Nordic Capital Funds
are 60 institutions, e.g. pension funds, banks and insurance
companies
The Nordic region represents 20% of
committed capital, Europe 30%,
the US 40% and rest of the world 10%
Investments:
| Investment year |
Company |
Industry |
Turnover (EUR m)* |
Exit |
|
2005
|
Luvata >
|
Metal solutions manufacturing and heat transfer technology
|
1625
|
|
|
2005
|
Nycomed |
Pharmaceuticals
|
|
2011
|
|
2006
|
Brightpoint |
Mobile phone distributor
|
|
2007
|
|
2006
|
Menigo >
|
Food service distributor
|
543
|
|
|
2006
|
Capio >
|
Healthcare services
|
1210
|
|
|
2007
|
Unilabs >
|
Laboratory and radiology services
|
621
|
|
|
2007
|
Thule >
|
Leisure, outdoor industry
|
666
|
|
|
2007
|
Nefab >
|
Packaging solutions provider
|
347
|
|
|
2008
|
CPS Color >
|
Colour tinting solutions
|
190
|
|
|
2008
|
ConvaTec >
|
Ostomy, wound care and hospital products
|
1309
|
|
|
2006
|
Fougera Pharmaceuticals Inc. (formerly Nycomed US Inc.) |
Specialty pharmaceuticals
|
|
2012
|
* 2012 sales for companies still in portfolio; sales at exit for divested companies
Contact information:
Nordic Capital Limited
26 Esplanade, St Helier Jersey JE2 3QA
Tel: +44 1534 605 100
Fax: +44 1534 605 199
For all investor communications: investor@nordiccapital.je
